ABSTRACT The influence of dietary fructooligosaccharides (FOS) on bioavailability of genistein and daidzein in rats was estimated by measuring their concentrations in plasma collected from three different veins and in urine after a single intragastric administration of isoflavone conjugates. Sprague-Dawley male rats (6 wk old, n ϭ 22) were fed a purified control (AIN-93G) diet or a FOS diet (AIN-93G ϩ 5% FOS) for 7 d. A single dose of soy isoflavone conjugates, i.e., 8.5 mg as genistein and 33 mg as daidzein/kg body, was administered via a stomach tube at d 5. Blood samples were collected after administration via catheters in the portal and central veins and by puncture of the tail vein. The isoflavones in plasma and urine were analyzed by time-resolved fluoroimmunoassay. The genistein concentration in the portal blood increased rapidly, reaching a peak of 3.5 mol/L in both groups at 1 h after administration. The concentrations in the central and tail venous blood were approximately half of those in the portal blood. In the FOS-fed group, both genistein and daidzein remained detectable at 24 and 48 h in the tail venous plasma. The urinary excretion of both isoflavones in the 24-to 48-h period after administration was significantly higher in the FOS-fed group than in the control group. The difference between the portal and central veins indicated hepatic uptake, probably leading to conjugation of aglycones and excretion into bile. FOS modified the absorption and enterohepatic recirculation of isoflavones. J. Nutr. 131: 787-795, 2001.
Several constituents of plants have estrogen-like physiologic effects. These constituents are called phytoestrogens (Murkies et al. 1998, Price and Fenwick 1985) . Isoflavones (genistein and daidzein) in soybeans and lignans (enterolactone and enterodiol) formed in the intestine from their precursors in various grains, seeds, fruits, some vegetables and tea are commonly known phytoestrogens Mazur 1997, Mazur et al. 1998) . Dietary phytoestrogens may prevent sex hormone-related diseases, such as breast cancer and prostate cancer, through mechanisms that are insufficiently documented at present (Adlercreutz et al. 1982 , Adlercreutz 1984 and 1990 , Attalla et al. 1997 , Landstrom et al. 1998 ). On the other hand, they may also prevent postmenopausal osteoporosis through an estrogenic effect (Arjmandi et al. 1996) . For instance, intake of soy products (Arjamandi et al. 1998 , Omi et al. 1994 , genistein (Anderson et al. 1998 , Ishimi et al. 1999 , daidzein or other phytoestrogens (Draper et al. 1997 , Ishida et al. 1998 ) has been found to prevent postovariectomized bone loss in rats and mice. It is important to clarify the levels of phytoestrogens in the blood attained through daily intake. Japanese people consume soy products containing ϳ30 -50 mg of isoflavonoids daily, and this appears to play an important role in the prevention of cancer (Arai et al. 2000 , Kimira et al. 1998 , Watanabe et al. 1997 . However, few studies regarding the kinetics of isoflavones in blood have been reported. Moreover, the intestinal environment is likely to influence their absorption. Almost all phytoestrogens in food exist as glycosides, such as genistin and daidzin; thus, to obtain physiologic activity, it is necessary to hydrolyze the glycosidic bonds for intestinal absorption to occur , Murkies et al. 1998 , Price and Fenwick 1985 . These glycosidic bonds are hydrolyzed by glucosidases of intestinal bacteria, such as Lactobacilli, Bacteroides and Bifidobacteria (Hawksworth et al. 1971 , Xu et al. 1995 . Fructooligosaccharides (FOS), 2 a mixture of indigestible and fermentable sugars, have beneficial effects. FOS stimulate the growth of bifidobacteria in the intestine (Hidaka et al. 1986 ), increase Ca, Mg and Fe absorption and enhance bone calcium stores in rats (Ohta et al. 1995a (Ohta et al. , 1996 (Ohta et al. and 1998 . Many of the effects of FOS feeding take place in the large intestine (Ohta et al. 1994 (Ohta et al. , 1995b (Ohta et al. and 1997 . Consequently, we postulate that dietary FOS may affect bioavailability of phytoestrogen glycosides and therefore improve their absorption form in the gut.
In this study, the kinetics of isoflavones in rats fed a FOS-supplemented diet or a control diet were examined by measuring genistein and daidzein concentrations in blood collected from the portal, central and tail veins, and by measuring urinary excretion over a 48-h period after a single administration of soy isoflavones.
MATERIALS AND METHODS
Experimental procedure. Male Sprague-Dawley rats (6 wk old; n ϭ 22, Clea Japan, Tokyo, Japan) were housed in individual stainless steel wire-mesh cages in a room at 25°C and 55% relative humidity with a 12-h light:dark cycle; rats had free access to food and water. This study was approved by the Animal Studies Committee of Meiji Seika Bioscience Laboratories, and rats were maintained in accordance with the guidelines for the care and use of laboratory animals of Meiji Seika Bioscience Laboratories.
The rats were fed a pelleted diet (MF, oriental Yeast, Tokyo, Japan) for a 1-wk adaptation period. The rats (n ϭ 22) were randomly assigned to two groups of 11 rats each, a purified control diet (AIN-93G) group and the FOS diet (AIN-93G ϩ 5% FOS) group (Reeves et al. 1993) . The composition of each of the diets is shown in Table  1 . The experimental period was 7 d. All rats were fed 15 g diet/d on d 1 and 2 and 20 g/d on d 3-7, and were allowed free access to deionized water throughout the experimental period. Five rats from each group were used for sampling portal and central venous blood. The remaining 6 rats in each group were used for sampling tail venous blood.
On d 3 of experimental feeding, two catheters were inserted in rats under sodium pentobarbital anesthesia to sample portal and central venous blood. The tip of a portal cannula (silicone tube 0.5-mm i.d., 1-mm o.d., with a 20-mm polyethylene tip SP-31, Natume, Tokyo, Japan) was inserted directly into the portal vein. A central venous cannula was inserted into the jugular vein and located in the central vein 3 cm from the insertion. The cannula was filled with heparinized (30 g/L) saline solution except at sampling times. These tubes were fastened to the abdominal wall, and the tip of the tube placed behind the neck under the skin without a harness to avoid any stress.
Isoflavone conjugates were administered to all rats in this experiment. Fujiflavone P40 [isoflavone content: 40% (daidzin, malonyldaidzin, acetyldaidzin and daidzein account for 20.4, 0.1, 1.1 and 0.3%, respectively; genistin, acetylgenistin and genistein account for 4.6, 0.3 and 0.1%, respectively; and glycitin and glycitein together account for ϳ13%)] was obtained from Fujicco, Kobe, Japan. FOS (Meioligo-P, Meiji Seika Kaisha, Tokyo, Japan) is a mixture of 42% 1-kestose, 46% nystose and 9% 1F-␤-fructofuranosylnystose.
Isoflavone (Fujiflavone P40) for administration to all rats was freshly prepared as a 1 mL suspension in water and a single dose [isoflavones: 100 mg (conjugates)/kg body (8.5 mg as genistein and 33 mg as daidzein)] was administered via a stomach tube. The rats were not restricted from eating throughout the experiment.
Two days after catheter implantation, blood was collected through the silicone tube connected on the neck to the portal and central veins. Blood (100 L) was collected at 0, 1, 3, 6, 24 and 48 h after administration of isoflavones from the portal and central veins of 5 rats in each diet group under unanesthetized and unrestrained conditions; for the other rats (n ϭ 6), blood was collected from the tail vein at these same times by the method of Hara et al. (1984) .
Urine samples were collected during the periods 0 -24 h and 24 -48 h postadministration. NaN 3 (0.003 mol/L) and ascorbic acid (ϳ1 g/L) were added to the urine storage bottles to prevent oxidation of isoflavones. Each urine sample was stored separately in a bottle at Ϫ80°C until the assay.
Reagents. Bovine serum albumin (BSA) and sulfates (EC 3.1.6.1; catalog no. S-9626) were purchased from Sigma Chemical (St Louis, MO). ␤-Glucuronidase (EC 3.2.1.31; catalog no. 1585665) was from Boehringer (Mannheim, Germany). The assay buffer was 50 mmol/L Tris-HCl buffer, pH 7.8, containing (per L) 8.78 g NaCl, 0.5 g sodium azide, 5 g BSA and 0.1 g Tween 40. For enzymatic hydrolysis of the isoflavone conjugates in urine, 0.1 mol/L acetate buffer, pH 5.0, was used. Standards of genistein and daidzein were synthesized as previously described (Adlercreutz et al. 1986, Wähälä and Hase 1991) Time-resolved fluoroimmunoassay (TR-FIA) for measuring of serum and urinary genistein and daidzein. One milliliter of 0.1 mmol/L acetate buffer (pH 5.0) containing 200 U/L ␤-glucuronidase and 2000 U/L sulfatase (hydrolysis reagent) was added to plastic tubes containing 50 L of urine. The samples were mixed and incubated overnight at 37°C; 20 L of the resulting solution was used for TR-FIA. , Wang et al. 2000 .
Immunogen synthesis, immunization and labeling of isoflavonoid derivatives with europium chelate in the case of genistein and daidzein were described previously , Wang et al. 2000 .
The TR-FIA methods used for assay of isoflavones in plasma and urine are shown in Figure 1 . Before the assay, microstrips coated with goat anti-rabbit immunoglobulin G were prewashed using 1296 -026 DELFIA platewash (Wallac, Oy Turku, Finland) . Of the standard, serum or hydrolyzed urine samples, 20 L was pipetted into the microstrips; then 100 L of antiserum in 50 mmol/L Tris-HCl buffer containing 5 g/L BSA (pH 7.8) for genistein or daidzein, (antiserum diluted 1:50,000 and 1:40,000, respectively) and 100 L of europiumlabeled genistein or daidzein (diluted 1:400,000 and 1:40,000, respectively) were added per well. The strips were placed on a 1296 -003 DELFIA shaker (Wallac) and shaken slowly at room temperature for 90 min, then washed with a DELFIA platewasher using the no. 29-T3 program. DELFIA enhancement solution (200 L) 1244 -105 (Wallac) was added to each well and the strips were shaken slowly for an additional 5 min. Fluorescence was read using the DELFIA Victor 1420 multilabel counter and the accompanying software, version 1.0, for data analysis. The final result was calculated by means of the following formula:
Final result ϭ Concentration (read) ϫ dilution factor (nmol/L) The TR-FIA method, including hydrolysis and extraction, gives the most specific results for plasma or serum, but we used a modified method that omitted extraction of the unhydrolyzed plasma because the quantities of several blood samples were insufficient for extraction. The direct method for assay of genistein and daidzein in serum or plasma measures only the free aglycones, the 4Ј-monosulfates and the 4Ј-monoglucuronides, and gives lower (ϳ30% in rats) values than those obtained by gas chromatography-mass spectrometry (GC-MS) analysis.
Urinary isoflavones were analyzed by a method including a hy- drolysis step. The mean value of urinary (hydrolyzed) genistein was much higher by the TR-FIA method than by the GC-MS method, but that of daidzein was similar by both methods. However, there was a significant correlation between the values of genistein for urine as determined by TR-FIA and GC-MS (r ϭ 0.880, P Ͻ 0.001). The urinary genistein concentration was adjusted to correspond to the GC-MS values by means of the formula: y ϭ 0.465x Ϫ 0.696 .
The areas under the curve (AUC) of change in the plasma isoflavones were calculated by the following formula:
where t n is number n sampling time (h) and C n is the plasma isoflavone concentration at t n .
Analysis of cecal contents. The pH of cecal contents was measured directly using a compact pH electrode (B-112, Horiba, Kyoto, Japan). The concentration of organic acids in the cecal contents was analyzed quantitatively by HPLC according to a method reported previously (Kritchevsky and Bonfield 1997) . Cecal contents were adjusted to a volume of 20 mL with deionized water and homogenized with a teflon homogenizer. After undergoing centrifugation for 10 min at 3000 ϫ g, the supernatants were analyzed by HPLC.
Statistical analyses. Values were expressed as means and SEM After examining the equality by Levene's test, if there was a significant difference (P Ͻ 0.05), each value was converted to the logarithmic value. Three-way ANOVA was performed to determine the main effects of diet, the time course of changes, the type of veins from which blood was collected and the interactions with respect to isoflavone concentrations in the portal and central venous blood. Two-way ANOVA was used to determine the main effects of diet and the time course of changes, and the interactions with respect to isoflavone concentrations in blood from the tail vein and hepatic uptake. Tukey's test (Dawson-Saunder and Trapp 1994) was used for comparison of means within a factor. The effect of absorption of isoflavones calculated from the areas under the plasma concentration time course curves in the case of blood from the portal, central and tail veins, and the effect of FOS feeding on food intake, body weight gain and cecal wet weight, pH and concentrations of organic acids were examined by Student's unpaired t test; the equality of variance was determined using Levene's test. Differences were considered significant at P Ͻ 0.05. All statistical analyses were performed using the SPSS package program version 6.1 J (Chicago, IL) and Excel 97 with Microsoft Windows 95 or 98.
RESULTS
Food intake and animal weight. There were no significant differences in food intake (130 g for all rats in 7 d) and body weight gain between the control (50.2 Ϯ 1.5 g) and FOS-fed (49.3 Ϯ 4.6 g) groups.
Cecal wet weight, pH and concentrations of organic acids. After 1 wk of feeding, cecal contents wet weight was significantly greater in rats fed the FOS diet than in those fed the control diet (P Ͻ 0.01). Cecal pH was significantly lower in rats fed FOS (P Ͻ 0.01) compared with the control. Lactate, propionate and butyrate concentrations were significantly higher in rats fed the FOS diet than in those fed the control diet (P Ͻ 0.05 or 0.01). There was no significant difference between the FOS-fed and control rats in concentrations of succinate and acetate ( Table 2) .
Portal and central venous plasma genistein and daidzein concentrations. Genistein concentrations in portal and central venous plasma after administration of a single dose of isoflavones are shown in Figure 2 A and B, respectively. Three-way ANOVA showed that the three main effects (diet, time and vein) and the interaction (time and vein) were significant (P Ͻ 0.002) for genistein ( Table 3 ). In the control rats, the genistein concentrations in portal blood reached a peak at 1 h after administration (3.5 Ϯ 0.7 mol/L) and decreased linearly thereafter. In the FOS-fed group also, the genistein concentrations reached a peak at 1 h (3.5 Ϯ 1.0 mol/L) and declined rapidly during the period up to 3 h after isoflavone administration (1.7 Ϯ 0.4 mol/L); however, a small second peak appeared at 6 h after administration (2.0 Ϯ 0.5 mol/L). At 48 h after administration, the genistein concentration tended to be higher in the FOS-fed group (38.8 Ϯ 10.5 nmol/L) than in the control group (7.2 Ϯ 2.0 nmol/L) (P ϭ 0.09). The genistein concentration in central venous plasma was approximately half of the portal blood concentration at each time point during the 1-to 12-h period after isoflavone administration in both the control group and the FOS-fed group. There was a significant difference in the genistein concentration between the portal vein and the central vein plasma samples at 1 h after isoflavone administration in both the control and FOS-fed rats (P Ͻ 0.05). Three-way ANOVA showed that the two main effects (time and vein) and the interaction (between diet and vein, between time and vein, and among diet, time and vein) were significant (P Ͻ 0.009) for daidzein (Table 3) . Daidzein concentrations in portal and central venous plasma after administration of a single dose of isoflavones are shown in Figure 3 A and B, respectively. The daidzein concentration in portal blood reached a peak at 1 h (6.3 Ϯ 1.6 mol/L) and was slightly lower at 3 and 6 h after administration (5.2 Ϯ 1.4 and 5.0 Ϯ 1.4 mol/L, respectively) in the control group. In the FOS-fed rats, the daidzein concentration in portal blood reached a peak at 6 h (5.0 Ϯ 2.2 mol/L) and declined thereafter, but there were no significant differences among the values at 1, 3 and 6 h after administration. There was a significant difference in the daidzein concentration in portal blood between the control and the FOS-fed rats at 1 h after administration of isoflavones (P Ͻ 0.05). In the control group, the daidzein concentration in the central venous blood reached peaks at 3 and 6 h (2.5 Ϯ 0.6 and 2.5 Ϯ 0.7 mol/L, respectively) and declined thereafter. In the FOS-fed group, the daidzein concentration in central venous blood reached a peak at 1 h (3.4 Ϯ 1.3 mol/L), was slightly lower at 3 h but had increased again at 6 h after administration.
Correlations existed between the portal and the central venous blood concentrations for both genistein (r 2 ϭ 0.962, P Ͻ 0.001) and daidzein concentrations (r 2 ϭ 0.833, P Ͻ 0.001).
Tail venous plasma genistein and daidzein concentrations. Genistein and daidzein concentrations were measured in separate rats in tail venous plasma; the values are shown in Figure 4 A and B, respectively. Two-way ANOVA showed that the two main effects (diet and time) and the interaction (diet and time) were significant (P Ͻ 0.004) for genistein, and the main effect (time) and the interaction (diet and time) for daidzein (Table 3 ). In the control group, the genistein concentration was maximal (1.9 Ϯ 0.4 mol/L) at 1 h after administration and decreased thereafter. In the FOS-fed group, To test the main effects and interaction of feeding diets, the time course of changes in plasma isoflavones and the type of veins from which blood was collected, three-way ANOVA was used.
TABLE 3

Three-and two-way ANOVA of genistein and daidzein concentrations in portal, central and tail venous plasma, and hepatic uptake in rats fed the control diet or the 5% fructooligosaccharide (FOS) diet 1,2
Main effects Interactions
2 To test the main effects of interaction of feeding diets and the time course of changes in plasma isoflavones, two-way ANOVA was used. NS: Not significant, P Ն 0.05. the genistein concentration was elevated at 1 h and did not change until after 6 h of administration. The genistein concentrations were significantly higher in the FOS-fed group than in the control group at 24 and 48 h after administration (P Ͻ 0.05). The daidzein concentration reached a maximum at 1 h in the control group (2.2 Ϯ 0.6 mol/L) but the peak area was delayed until 3-6 h postadministration in the FOSfed group.
The central and the tail venous blood concentrations were correlated for both genistein (r 2 ϭ 0.887, P Ͻ 0.001) and daidzein (r 2 ϭ 0.829, P Ͻ 0.001). Absorption of genistein and daidzein. Genistein absorption calculated from the areas under the plasma concentration curves for portal, central and tail venous blood in rats fed the control diet and the FOS diet during the periods 0 -6 h, 6 -48 h and 0 -48 h after isoflavone administration is shown in Table 4 . On the basis of the concentrations in plasma from the three veins of the FOS-fed group compared with the control group, no significant differences in the absorption of genistein existed during the 0-to 6-h period after administration. During the 6-to 48-h period after administration, the genistein areas under the concentration curves of the central and tail venous plasma concentrations were significantly higher in the FOS-fed group than in the control group (P Ͻ 0.05). During the 0-to 48-h period, the genistein areas under the concentration curves in tail venous plasma were also higher in the FOS-fed group than in the control group (P Ͻ 0.01). For daidzein, there was a significant difference between areas under the concentration curves of the FOS-fed and control groups during the 0-to 48-h period in the tail vein samples (P Ͻ 0.05) ( Table 4) .
Hepatic uptake of genistein and daidzein. We assessed the hepatic uptake of isoflavones into the liver by comparing the concentrations in portal and central venous plasma (Fig. 5  A and B) . Two-way ANOVA showed that time was a significant effect (P Ͻ 0.0001) for genistein and daidzein (Table 3 ). The hepatic uptake of both genistein and daidzein was greater 1 h after administration of a single dose of isoflavones compared with the values at other time points. There were no significant differences between the control and the FOS-fed groups at any time.
Urinary excretion of genistein was not different during the 0-to 24-h period between the two dietary groups after administration of a single dose of isoflavones. However, the excretion was significantly higher in the FOS-fed group (Urine-2 in Table 5 ) than that in the control group during rgw 24-to 48-h period after administration (P Ͻ 0.01). The excretion of daidzein did not differ between rats fed the control and FOS diets at any time. The amount of genistein recovered in the urine was ϳ11 and 14% in the control and FOS-fed groups, respectively. The amount of daidzein recovered in urine was 21-23% in both groups.
DISCUSSION
We examined the changes in circulating levels of isoflavones after intragastric administration of a single dose of isoflavones to rats by measuring the genistein and daidzein concentrations in portal, central and tail venous plasma, and the urinary excretion of these compounds. Our assumptions were as follows: 1) the concentrations of genistein and daidzein in portal blood should be a reflection of the degree of absorption; 2) the concentrations in the tail venous blood represent the peripheral blood concentrations; 3) the difference between the portal and central venous blood concentrations is indicative of hepatic uptake and biliary excretion; and 4) the difference between the central and tail venous blood concentration reflects the elimination of isoflavone by the kidneys.
Phytoestrogens occur mainly as glucuronide or sulfate conjugates in plasma and urine. We measured only some of the isoflavone conjugates and free aglycones present in plasma by TR-FIA, and this assay was carried out directly without hydrolysis and extraction. The conjugates are mainly 4Ј-monosulfate and monoglucuronides, but some other conjugates seem to have been included because the main isoflavone conjugates in rat plasma and urine are 7-O-glucuronides (Sfakianos et al. 1997) . We compared the values in direct and extracted samples of rat plasma (n ϭ 15), and the mean values by the direct method were 70% of the values by the extracted method (data not shown). Therefore, the direct values are underestimates, but the difference in isoflavone concentrations between the different venous plasmas and between rats fed the FOS and control diets could be determined. Our results suggest, however, that the 4Ј-conjugates of genistein and daidzein occur in relatively large amounts after an isoflavone load.
Isoflavone conjugates may be deglycosylated by the strong acid in the stomach. Enzymes such as ␤-glucosidase produced by the intestinal microflora before absorption are considered to 1 Values are means Ϯ SEM, n ϭ 5-6. * Significantly different from the control rats by Student's t test after Levene's test for equality (P Ͻ 0.05).
2 Urine-1: Urine samples from the rats taking portal and central venous blood; Urine-2: Urine samples from the rats taking tail venous blood. be responsible for the hydrolysis. Recently it was shown in humans that genistein and daidzein can be detected in blood within 15 min after consumption of soy protein (textured vegetable protein) (Bowey et al. 1998) , suggesting hydrolysis in the upper gastrointestinal tract. Day et al. (1998) reported that genistein 7-glucoside and daidzein 7-glucoside are rapidly deglycosylated by cell-free extracts from human small intestine and liver, and they suggested that deglycosylation of isoflavones by human cytosolic ␤-glucosidase could be an important first step in the metabolism of these compounds, independent of deglycosylation by the colonic microflora. Ioku et al. (1998) also measured ␤-glucosidase activity in the small intestine of rats using flavonoid glucosides as substrates, and their findings suggested that dietary flavonoid glucosides are hydrolyzed primarily in the jejunum, thereby liberating aglycones. In this study, the concentrations of both genistein and daidzein in portal blood rapidly reached a peak (within 1 and 3 h, respectively) after a single dose of isoflavones. This finding indicates that these isoflavones are readily absorbed in the small intestine after intragastric administration. Piskula (2000) reported that in tail vein plasma, total daidzein and genistein reached maximum concentrations in food-deprived (intragastric administration) rats at 7 min after administration of their aglycones.
Twenty-four hours after administration, the concentrations of genistein and daidzein in blood from all three veins were Ͻ 10% of the peak levels observed. The intestinal transit time of the diet in rats has been estimated to be ϳ20 -30 h (Sakaguchi et al. 1987) . The length of time until disappearance of both isoflavones was similar to the intestinal transit time. These results suggest that in rats, the peripheral blood concentration reflects mainly intestinal absorption, and that genistein and daidzein do not remain in the blood and probably do not remain in the body for a long time.
In the case of both genistein and daidzein, good correlations between the portal and central venous plasma concentrations were observed in this study. Indeed, the central venous plasma isoflavone concentrations were nearly half the portal venous concentration during the 1-to 12-h period after administration. This result indicates that about half of the genistein and/or daidzein absorbed was taken up into the liver, and this metabolic pathway is similar to that of endogenous estrogens (Adlercreutz and Martin 1980) . Also, good correlations between the central and tail venous blood concentrations were observed for both genistein and daidzein. According to the results of this study, 15% of plasma genistein and 35% of plasma daidzein disappeared from the peripheral circulation by urinary excretion. Tew et al. (1996) suggested that genistein has lower bioavailability than daidzein because of the low urinary output of genistein. However, Sfakianos et al. (1997) examined the intestinal absorption, biliary excretion and metabolism of genistein using adult female rats fitted with indwelling biliary cannulas and found that genistein was absorbed from the intestines very well; it was excreted mostly into the bile, and only a small portion appeared in the urine. Both genistein and daidzein are converted to sulfate and glucuronide conjugates in rats. Daidzein may be eliminated more rapidly in the urine than genistein. Estrogens with three hydroxyl groups are more abundantly excreted into the bile (Adlercreutz and Luukkainen 1967) ; because of the three hydroxyl groups, genistein is more likely than daidzein to be excreted rapidly in bile. In other words, it seems that the isoflavonoid concentration in peripheral blood is probably regulated through biliary excretion. A likely reason for the greater excretion of compounds with three hydroxyl groups compared with those with two is the formation of polar double conjugates (Adlercreutz et al. 1973) .
The recovery of genistein in urine was 10 -12% and 13-15% of the amount administered in the case of the control and FOS-fed groups, respectively. The recovery of daidzein in urine was ϳ23% in both groups. Landstrom et al. (1998) reported the urinary recovery during two metabolic periods was 1 and 3% for genistein and 11 and 28% for daidzein in rats after tumor transplantation and soy intake. In the study of King (1998) , the recovery of genistein and daidzein in urine of rats was 11.9 and 17.4%, respectively.
The data obtained in this study demonstrate for the first time that FOS modify the bioavailability of isoflavones. Through observation of cecal contents weight, pH and composition of organic acids, we concluded that the rats fed the FOS diets for 7 d were almost fully adapted to FOS. In this study, genistein and daidzein remained detectable for a significantly longer period in the tail venous blood of rats fed the FOS diet compared with the controls. The absorption of genistein, as calculated on the basis of the concentrations in portal, central and tail venous blood during the 6-to 48-h period after administration, was significantly higher in rats fed the FOS diet than in controls, but the absorption of daidzein did not differ. This indicates that FOS enhanced the enterohepatic recirculation and/or large intestinal absorption of genistein. Adlercreutz (1962) suggested that the proportions of estrogen metabolites in the enterohepatic recirculation already excreted into bile increased transiently in the 6-to 10-h period after the start of oral administration of estradiol. In this study, a significant difference between the control and FOS-fed groups in the genistein concentration in the tail venous blood became evident 6 h after administration of the isoflavones. FOS are indigestible because they are resistant to hydrolysis by mammalian enzymes, and they stimulate the growth of intestinal bifidobacteria. In this manner, dietary FOS may increase ␤-glucosidase activity in the large intestine (Hidaka et al. 1986 ). As indicated above, in FOS-fed rats, a portion of the isoflavone-glycosides consumed was likely to have been deglycosylated and absorbed as aglycones in the large intestine. Our findings regarding urinary isoflavone excretion also support this hypothesis because the extent of excretion of both genistein and daidzein was higher in rats fed the FOS diet than in control rats during the 24-to 48-h period after administration. The relative absorption of genistein, calculated on the basis of the urinary excretion, was ϳ20% higher in FOS-fed rats than in control rats. FOS may be useful for maintaining elevated blood levels of isoflavones, especially in the case of genistein. Additionally, we speculate that FOS may enhance the metabolism of isoflavones, particularly for daidzein to metabolites such as equol and O-desmethylangolensin. This could explain the difference observed between genistein and daidzein concentrations in plasma when the two dietary groups were compared. Isoflavonoids undergo extensive metabolism by gut microflora (Heinonen et al. 1999) . Considerable evidence exists showing extensive interindividual variation in isoflavone metabolism in humans (Lampe et al. 1998 , Rowland et al. 2000 , Watanabe et al. 1997 , Xu et al. 1995 . A carbohydrate-rich diet increases equol production (Lampe et al. 1998 , Rowland et al. 2000 . However, rats are constitutive equol producers in contrast to humans (King 1998 , Landstrom et al. 1998 . FOS can change the composition of gut microflora, and may change the production of daidzein metabolites in rats. However, further studies should be conducted.
In conclusion, with a single administration of isoflavones, both genistein and daidzein were immediately absorbed; their concentrations in peripheral blood increased, but their clearance was also rapid. Our findings suggest that the main factor responsible for the disappearance of both isoflavones, genistein and daidzein, is hepatic uptake/biliary excretion. Dietary FOS may prolong the clearance of isoflavones, especially genistein, by enhancing the large intestinal absorption of these compounds.
ACKNOWLEDGMENTS
The skillful technical assistance of Adile Samaletdin is acknowledged. We thank Tarja Nurmi for analysis of free aglycones of isoflavones in Fujiflavone P40 after hydrolysis by HPLC to calculate the recovery of genistein or daidzein in urine, and Witold Mazur for valuable suggestions for this paper.
